{"protocolSection":{"identificationModule":{"nctId":"NCT01662960","orgStudyIdInfo":{"id":"HN 4404"},"secondaryIdInfos":[{"id":"NIH R01 HD068565","type":"OTHER","domain":"Einstein Healthcare Network"}],"organization":{"fullName":"Albert Einstein Healthcare Network","class":"OTHER"},"briefTitle":"Visual Feedback Therapy for Treating Individuals With Hemiparesis Following Stroke","officialTitle":"Visual Feedback Therapy for Treating Individuals With Hemiparesis Following Stroke"},"statusModule":{"statusVerifiedDate":"2020-06","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2012-09-07","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2017-02-27","type":"ACTUAL"},"completionDateStruct":{"date":"2017-02-27","type":"ACTUAL"},"studyFirstSubmitDate":"2012-08-08","studyFirstSubmitQcDate":"2012-08-09","studyFirstPostDateStruct":{"date":"2012-08-13","type":"ESTIMATED"},"resultsFirstSubmitDate":"2019-02-12","resultsFirstSubmitQcDate":"2019-02-12","resultsFirstPostDateStruct":{"date":"2019-05-13","type":"ACTUAL"},"lastUpdateSubmitDate":"2020-06-19","lastUpdatePostDateStruct":{"date":"2020-06-30","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Steve Jax","investigatorTitle":"Institute Scientist","investigatorAffiliation":"Albert Einstein Healthcare Network"},"leadSponsor":{"name":"Albert Einstein Healthcare Network","class":"OTHER"}},"oversightModule":{"oversightHasDmc":false},"descriptionModule":{"briefSummary":"The purpose of the study is to determine whether an existing treatment for problems that participants have with making movements after a stroke can be performed at home.","detailedDescription":"This study will compare two forms of home-based treatment for post-stroke problems making movements with the arms and hands. After initial pre-treatment assessments, participants will complete 4 weeks of treatment, with assessments after each week of treatment and 3 months after the completion of treatment."},"conditionsModule":{"conditions":["Hemiparesis","Stroke"],"keywords":["stroke","hemiparesis","arm movement","sensory functioning"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"TRIPLE","whoMasked":["PARTICIPANT","CARE_PROVIDER","OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":72,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Mirror therapy","type":"EXPERIMENTAL","description":"4 weeks of home-based mirror therapy. Participants practiced making movements with mirrored visual feedback of the low-functioning arm.","interventionNames":["Behavioral: Mirror therapy"]},{"label":"Divider therapy","type":"ACTIVE_COMPARATOR","description":"4 weeks of home-based divider therapy (control therapy to mirror therapy; mirror replaced by a divider). Participants practiced making movements with no visual feedback of the low-functioning arm.","interventionNames":["Behavioral: Divider therapy"]}],"interventions":[{"type":"BEHAVIORAL","name":"Mirror therapy","description":"A home-based therapy involving mirrored visual feedback","armGroupLabels":["Mirror therapy"]},{"type":"BEHAVIORAL","name":"Divider therapy","description":"A home-based therapy involving removed visual feedback.","armGroupLabels":["Divider therapy"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Upper Extremity Fugl-Meyer","description":"This test measures impairment-level ability to move the arm and hand. Scores range from 0 to 66, with higher scores indicating greater ability to move the arm and hand.","timeFrame":"Immediately after 1 month of treatment"},{"measure":"Action Research Arm Test","description":"The test measures the ability to complete simulated everyday tasks with the arm. Scores range from 0 to 54, with higher scores indicating better performance.","timeFrame":"1 month"},{"measure":"Rivermead Assessment of Somatosensory Performance","description":"This test measures the integrity of sensory perception of the arm. The score is the proportion of items answered correctly, and ranges from 0 to 1 with higher scores indicating better performance.","timeFrame":"1 month"},{"measure":"Virtual-reality Assessment of Navigation","description":"This test measures the ability to detect lateralized attention problems in a simulated navigation test. Evidence for lateralized attentional problems was defined as a 20% difference in item detection between the left and right side.","timeFrame":"1 month"}],"secondaryOutcomes":[{"measure":"Stroke Impact Scale","description":"This test measures the self-reported ability to complete everyday tasks with the arm. Total scores for all items are reported. The scale ranged from 0 to 300, with higher scores indicating higher self-reported ability.","timeFrame":"1 month"},{"measure":"Wolf Motor Function Test","description":"The test measures the ability to completed simulated everyday tasks with the arm. The scale ranged from 0 to 75, with higher scores indicating better performance.","timeFrame":"1 months"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* 6 months or more post-stroke\n* upper extremity Fugl-Meyer score between 10 and 50\n* no longer participating in upper-extremity physical or occupational therapy\n* sufficient comprehension ability to understand instructions\n\nExclusion Criteria:\n\n* previous head trauma, psychiatric illness or chronic exposure to medications that might be expected to have lasting consequences for the central nervous system (e.g., haloperidol, dopaminergics)\n* dementia","healthyVolunteers":false,"sex":"ALL","minimumAge":"21 Years","maximumAge":"85 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Steven Jax, Ph. D.","affiliation":"Albert Einstein Healthcare Network","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"Einstein Medical Center Elkins Park","city":"Elkins Park","state":"Pennsylvania","zip":"19027","country":"United States","geoPoint":{"lat":40.07706,"lon":-75.12684}}]}},"resultsSection":{"participantFlowModule":{"groups":[{"id":"FG000","title":"Mirror Therapy: High Functioning","description":"4 weeks of home-based mirror therapy. Participants practiced making movements with mirrored visual feedback of the low-functioning arm.\n\nHigh functioning was defined as pre-treatment upper extremity Fugl-Meyer score of 30-50."},{"id":"FG001","title":"Mirror Therapy: Low Functioning","description":"4 weeks of home-based mirror therapy. Participants practiced making movements with mirrored visual feedback of the low-functioning arm.\n\nLow functioning was defined as pre-treatment upper extremity Fugl-Meyer score of 10-29."},{"id":"FG002","title":"Divider Therapy: High Functioning","description":"4 weeks of home-based divider therapy (control therapy to mirror therapy; mirror replaced by a divider). Participants practiced making movements with no visual feedback of the low-functioning arm.\n\nHigh functioning was defined as pre-treatment upper extremity Fugl-Meyer score of 30-50."},{"id":"FG003","title":"Divider Therapy: Low Functioning","description":"4 weeks of home-based divider therapy (control therapy to mirror therapy; mirror replaced by a divider). Participants practiced making movements with no visual feedback of the low-functioning arm.\n\nLow functioning was defined as pre-treatment upper extremity Fugl-Meyer score of 10-29."}],"periods":[{"title":"End of 4 Week Treatment Period","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","numSubjects":"25"},{"groupId":"FG001","numSubjects":"23"},{"groupId":"FG002","numSubjects":"9"},{"groupId":"FG003","numSubjects":"15"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"24"},{"groupId":"FG001","numSubjects":"19"},{"groupId":"FG002","numSubjects":"8"},{"groupId":"FG003","numSubjects":"15"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"4"},{"groupId":"FG002","numSubjects":"1"},{"groupId":"FG003","numSubjects":"0"}]}]},{"title":"3 Month Follow-up","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","numSubjects":"24"},{"groupId":"FG001","numSubjects":"19"},{"groupId":"FG002","numSubjects":"8"},{"groupId":"FG003","numSubjects":"15"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"21"},{"groupId":"FG001","numSubjects":"16"},{"groupId":"FG002","numSubjects":"5"},{"groupId":"FG003","numSubjects":"13"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"3"},{"groupId":"FG001","numSubjects":"3"},{"groupId":"FG002","numSubjects":"3"},{"groupId":"FG003","numSubjects":"2"}]}]}]},"baselineCharacteristicsModule":{"groups":[{"id":"BG000","title":"Mirror Therapy: High Functioning","description":"4 weeks of home-based mirror therapy. Participants practiced making movements with mirrored visual feedback of the low-functioning arm.\n\nHigh functioning was defined as pre-treatment upper extremity Fugl-Meyer score of 30-50."},{"id":"BG001","title":"Mirror Therapy: Low Functioning","description":"4 weeks of home-based mirror therapy. Participants practiced making movements with mirrored visual feedback of the low-functioning arm.\n\nLow functioning was defined as pre-treatment upper extremity Fugl-Meyer score of 10-29."},{"id":"BG002","title":"Divider Therapy: High Functioning","description":"4 weeks of home-based divider therapy (control therapy to mirror therapy; mirror replaced by a divider). Participants practiced making movements with no visual feedback of the low-functioning arm.\n\nHigh functioning was defined as pre-treatment upper extremity Fugl-Meyer score of 30-50."},{"id":"BG003","title":"Divider Therapy: Low Functioning","description":"4 weeks of home-based divider therapy (control therapy to mirror therapy; mirror replaced by a divider). Participants practiced making movements with no visual feedback of the low-functioning arm.\n\nLow functioning was defined as pre-treatment upper extremity Fugl-Meyer score of 10-29."},{"id":"BG004","title":"Total","description":"Total of all reporting groups"}],"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"25"},{"groupId":"BG001","value":"23"},{"groupId":"BG002","value":"9"},{"groupId":"BG003","value":"15"},{"groupId":"BG004","value":"72"}]}],"measures":[{"title":"Age, Continuous","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"Years","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"60.7","spread":"12.3"},{"groupId":"BG001","value":"53.7","spread":"14.9"},{"groupId":"BG002","value":"55.9","spread":"9.7"},{"groupId":"BG003","value":"57.5","spread":"12.7"},{"groupId":"BG004","value":"57.3","spread":"13.0"}]}]}]},{"title":"Sex: Female, Male","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Female","measurements":[{"groupId":"BG000","value":"8"},{"groupId":"BG001","value":"9"},{"groupId":"BG002","value":"4"},{"groupId":"BG003","value":"4"},{"groupId":"BG004","value":"25"}]},{"title":"Male","measurements":[{"groupId":"BG000","value":"17"},{"groupId":"BG001","value":"14"},{"groupId":"BG002","value":"5"},{"groupId":"BG003","value":"11"},{"groupId":"BG004","value":"47"}]}]}]},{"title":"Ethnicity (NIH/OMB)","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Hispanic or Latino","measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"1"},{"groupId":"BG004","value":"3"}]},{"title":"Not Hispanic or Latino","measurements":[{"groupId":"BG000","value":"24"},{"groupId":"BG001","value":"22"},{"groupId":"BG002","value":"9"},{"groupId":"BG003","value":"14"},{"groupId":"BG004","value":"69"}]},{"title":"Unknown or Not Reported","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"}]}]}]},{"title":"Race (NIH/OMB)","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"American Indian or Alaska Native","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"}]},{"title":"Asian","measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"1"}]},{"title":"Native Hawaiian or Other Pacific Islander","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"}]},{"title":"Black or African American","measurements":[{"groupId":"BG000","value":"11"},{"groupId":"BG001","value":"10"},{"groupId":"BG002","value":"4"},{"groupId":"BG003","value":"7"},{"groupId":"BG004","value":"32"}]},{"title":"White","measurements":[{"groupId":"BG000","value":"12"},{"groupId":"BG001","value":"12"},{"groupId":"BG002","value":"5"},{"groupId":"BG003","value":"7"},{"groupId":"BG004","value":"36"}]},{"title":"More than one race","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"}]},{"title":"Unknown or Not Reported","measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"1"},{"groupId":"BG004","value":"3"}]}]}]},{"title":"Upper Extremity Fugl-Meyer","description":"This test measures impairment-level ability to move the arm and hand. Scores range from 0 to 66, with higher scores indicating greater ability to move the arm and hand.","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"score on a scale","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"39.1","spread":"6.1"},{"groupId":"BG001","value":"17.5","spread":"4.2"},{"groupId":"BG002","value":"39.9","spread":"7.8"},{"groupId":"BG003","value":"18.8","spread":"6.1"},{"groupId":"BG004","value":"28.1","spread":"12.1"}]}]}]},{"title":"Action Research Arm Test","description":"The test measures the ability to complete simulated everyday tasks with the arm. Scores range from 0 to 54, with higher scores indicating better performance.","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"score on a scale","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"36.1","spread":"9.9"},{"groupId":"BG001","value":"5.8","spread":"4.4"},{"groupId":"BG002","value":"36.3","spread":"13.3"},{"groupId":"BG003","value":"6.7","spread":"4.4"},{"groupId":"BG004","value":"20.3","spread":"17.1"}]}]}]},{"title":"Rivermead Assessment of Somatosensory Performance","description":"This test measures the integrity of sensory perception of the arm. The score is the proportion of items answered correctly, and ranges from 0 to 1 with higher scores indicating better performance.","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"Proportion of items correct","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0.72","spread":"0.17"},{"groupId":"BG001","value":"0.53","spread":"0.19"},{"groupId":"BG002","value":"0.79","spread":"0.20"},{"groupId":"BG003","value":"0.56","spread":"0.21"},{"groupId":"BG004","value":"0.63","spread":"0.21"}]}]}]},{"title":"Stroke Impact Scale","description":"This test measures the self-reported ability to complete everyday tasks with the arm. Total scores for all items are reported. The scale ranged from 0 to 300, with higher scores indicating higher self-reported ability.","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"score on a scale","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"215.9","spread":"26.4"},{"groupId":"BG001","value":"219.9","spread":"35.0"},{"groupId":"BG002","value":"226.3","spread":"15.3"},{"groupId":"BG003","value":"215.7","spread":"28.7"},{"groupId":"BG004","value":"218.4","spread":"30.2"}]}]}]},{"title":"Wolf Motor Function Test","description":"The test measures the ability to completed simulated everyday tasks with the arm. The scale ranged from 0 to 75, with higher scores indicating better performance.","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"score on a scale","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"48.8","spread":"9.5"},{"groupId":"BG001","value":"22.7","spread":"5.7"},{"groupId":"BG002","value":"50.8","spread":"14.4"},{"groupId":"BG003","value":"25.1","spread":"7.2"},{"groupId":"BG004","value":"35.8","spread":"15.5"}]}]}]},{"title":"Virtual-reality Assessment of Navigation","description":"This test measures the ability to detect lateralized attention problems in a simulated navigation test. Evidence for lateralized attentional problems was defined as a 20% difference in item detection between the left and right side.","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"proportion difference","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":".047","spread":".051"},{"groupId":"BG001","value":".056","spread":".059"},{"groupId":"BG002","value":".022","spread":".036"},{"groupId":"BG003","value":".063","spread":".086"},{"groupId":"BG004","value":".050","spread":".062"}]}]}]}]},"outcomeMeasuresModule":{"outcomeMeasures":[{"type":"PRIMARY","title":"Upper Extremity Fugl-Meyer","description":"This test measures impairment-level ability to move the arm and hand. Scores range from 0 to 66, with higher scores indicating greater ability to move the arm and hand.","populationDescription":"All participants who started the treatment were included. Data for any participants who failed to complete the treatment were imputed.","reportingStatus":"POSTED","paramType":"MEAN","dispersionType":"Standard Deviation","unitOfMeasure":"score on a scale","timeFrame":"Immediately after 1 month of treatment","groups":[{"id":"OG000","title":"Mirror Therapy: High Functioning","description":"4 weeks of home-based mirror therapy. Participants practiced making movements with mirrored visual feedback of the low-functioning arm.\n\nHigh functioning was defined as pre-treatment upper extremity Fugl-Meyer score of 30-50."},{"id":"OG001","title":"Mirror Therapy: Low Functioning","description":"4 weeks of home-based mirror therapy. Participants practiced making movements with mirrored visual feedback of the low-functioning arm.\n\nLow functioning was defined as pre-treatment upper extremity Fugl-Meyer score of 10-29."},{"id":"OG002","title":"Divider Therapy: High Functioning","description":"4 weeks of home-based divider therapy (control therapy to mirror therapy; mirror replaced by a divider). Participants practiced making movements with no visual feedback of the low-functioning arm.\n\nHigh functioning was defined as pre-treatment upper extremity Fugl-Meyer score of 30-50."},{"id":"OG003","title":"Divider Therapy: Low Functioning","description":"4 weeks of home-based divider therapy (control therapy to mirror therapy; mirror replaced by a divider). Participants practiced making movements with no visual feedback of the low-functioning arm.\n\nLow functioning was defined as pre-treatment upper extremity Fugl-Meyer score of 10-29."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"25"},{"groupId":"OG001","value":"23"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"15"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"43.8","spread":"9.4"},{"groupId":"OG001","value":"21.4","spread":"5.7"},{"groupId":"OG002","value":"42.8","spread":"8.7"},{"groupId":"OG003","value":"21.5","spread":"6.3"}]}]}],"analyses":[{"groupIds":["OG000","OG001","OG002","OG003"],"nonInferiorityType":"SUPERIORITY","nonInferiorityComment":"Test for the superiority of Mirror therapy over Divider therapy.","pValue":".443","pValueComment":"ANCOVA analysis with post-treatment score as the dependent variable, therapy type (Mirror therapy or Divider Therapy) as the independent variable, and pre-treatment score as the covariate. P-value reported is for the main effect of therapy type.","statisticalMethod":"ANCOVA","paramType":"Slope","paramValue":"2.2","ciNumSides":"TWO_SIDED"}]},{"type":"PRIMARY","title":"Action Research Arm Test","description":"The test measures the ability to complete simulated everyday tasks with the arm. Scores range from 0 to 54, with higher scores indicating better performance.","populationDescription":"All participants who started the treatment were included. Data for any participants who failed to complete the treatment were imputed.","reportingStatus":"POSTED","paramType":"MEAN","dispersionType":"Standard Deviation","unitOfMeasure":"score on a scale","timeFrame":"1 month","groups":[{"id":"OG000","title":"Mirror Therapy: High Functioning","description":"4 weeks of home-based mirror therapy. Participants practiced making movements with mirrored visual feedback of the low-functioning arm.\n\nHigh functioning was defined as pre-treatment upper extremity Fugl-Meyer score of 30-50."},{"id":"OG001","title":"Mirror Therapy: Low Functioning","description":"4 weeks of home-based mirror therapy. Participants practiced making movements with mirrored visual feedback of the low-functioning arm.\n\nLow functioning was defined as pre-treatment upper extremity Fugl-Meyer score of 10-29."},{"id":"OG002","title":"Divider Therapy: High Functioning","description":"4 weeks of home-based divider therapy (control therapy to mirror therapy; mirror replaced by a divider). Participants practiced making movements with no visual feedback of the low-functioning arm.\n\nHigh functioning was defined as pre-treatment upper extremity Fugl-Meyer score of 30-50."},{"id":"OG003","title":"Divider Therapy: Low Functioning","description":"4 weeks of home-based divider therapy (control therapy to mirror therapy; mirror replaced by a divider). Participants practiced making movements with no visual feedback of the low-functioning arm.\n\nLow functioning was defined as pre-treatment upper extremity Fugl-Meyer score of 10-29."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"25"},{"groupId":"OG001","value":"23"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"15"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"39.9","spread":"11.8"},{"groupId":"OG001","value":"7.1","spread":"5.0"},{"groupId":"OG002","value":"39.1","spread":"13.6"},{"groupId":"OG003","value":"7.7","spread":"5.6"}]}]}],"analyses":[{"groupIds":["OG000","OG001","OG002","OG003"],"nonInferiorityType":"SUPERIORITY","nonInferiorityComment":"Test for the superiority of Mirror therapy over Divider therapy.","pValue":".80","pValueComment":"ANCOVA analysis with post-treatment score as the dependent variable, therapy type (Mirror therapy or Divider Therapy) as the independent variable, and pre-treatment score as the covariate. P-value reported is for the main effect of therapy type.","statisticalMethod":"ANCOVA","paramType":"Slope","paramValue":"0.4","ciNumSides":"TWO_SIDED"}]},{"type":"PRIMARY","title":"Rivermead Assessment of Somatosensory Performance","description":"This test measures the integrity of sensory perception of the arm. The score is the proportion of items answered correctly, and ranges from 0 to 1 with higher scores indicating better performance.","populationDescription":"All participants who started the treatment were included. Data for any participants who failed to complete the treatment were imputed.","reportingStatus":"POSTED","paramType":"MEAN","dispersionType":"Standard Deviation","unitOfMeasure":"Proportion of items correct.","timeFrame":"1 month","groups":[{"id":"OG000","title":"Mirror Therapy: High Functioning","description":"4 weeks of home-based mirror therapy. Participants practiced making movements with mirrored visual feedback of the low-functioning arm.\n\nHigh functioning was defined as pre-treatment upper extremity Fugl-Meyer score of 30-50."},{"id":"OG001","title":"Mirror Therapy: Low Functioning","description":"4 weeks of home-based mirror therapy. Participants practiced making movements with mirrored visual feedback of the low-functioning arm.\n\nLow functioning was defined as pre-treatment upper extremity Fugl-Meyer score of 10-29."},{"id":"OG002","title":"Divider Therapy: High Functioning","description":"4 weeks of home-based divider therapy (control therapy to mirror therapy; mirror replaced by a divider). Participants practiced making movements with no visual feedback of the low-functioning arm.\n\nHigh functioning was defined as pre-treatment upper extremity Fugl-Meyer score of 30-50."},{"id":"OG003","title":"Divider Therapy: Low Functioning","description":"4 weeks of home-based divider therapy (control therapy to mirror therapy; mirror replaced by a divider). Participants practiced making movements with no visual feedback of the low-functioning arm.\n\nLow functioning was defined as pre-treatment upper extremity Fugl-Meyer score of 10-29."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"25"},{"groupId":"OG001","value":"23"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"15"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.76","spread":"0.18"},{"groupId":"OG001","value":"0.52","spread":"0.19"},{"groupId":"OG002","value":"0.79","spread":"0.18"},{"groupId":"OG003","value":"0.60","spread":"0.20"}]}]}],"analyses":[{"groupIds":["OG000","OG001","OG002","OG003"],"nonInferiorityType":"SUPERIORITY","nonInferiorityComment":"Test for the superiority of Mirror therapy over Divider therapy.","pValue":".93","pValueComment":"ANCOVA analysis with post-treatment score as the dependent variable, therapy type (Mirror therapy or Divider Therapy) as the independent variable, and pre-treatment score as the covariate. P-value reported is for the main effect of therapy type.","statisticalMethod":"ANCOVA","paramType":"Slope","paramValue":"-.002","ciNumSides":"TWO_SIDED"}]},{"type":"PRIMARY","title":"Virtual-reality Assessment of Navigation","description":"This test measures the ability to detect lateralized attention problems in a simulated navigation test. Evidence for lateralized attentional problems was defined as a 20% difference in item detection between the left and right side.","populationDescription":"No participants were administered the test in the post-treatment phase because no participant exhibited a baseline 20% difference in item detection between the left and right side.","reportingStatus":"POSTED","timeFrame":"1 month","groups":[{"id":"OG000","title":"Mirror Therapy: High Functioning","description":"4 weeks of home-based mirror therapy. Participants practiced making movements with mirrored visual feedback of the low-functioning arm.\n\nHigh functioning was defined as pre-treatment upper extremity Fugl-Meyer score of 30-50."},{"id":"OG001","title":"Mirror Therapy: Low Functioning","description":"4 weeks of home-based mirror therapy. Participants practiced making movements with mirrored visual feedback of the low-functioning arm.\n\nLow functioning was defined as pre-treatment upper extremity Fugl-Meyer score of 10-29."},{"id":"OG002","title":"Divider Therapy: High Functioning","description":"4 weeks of home-based divider therapy (control therapy to mirror therapy; mirror replaced by a divider). Participants practiced making movements with no visual feedback of the low-functioning arm.\n\nHigh functioning was defined as pre-treatment upper extremity Fugl-Meyer score of 30-50."},{"id":"OG003","title":"Divider Therapy: Low Functioning","description":"4 weeks of home-based divider therapy (control therapy to mirror therapy; mirror replaced by a divider). Participants practiced making movements with no visual feedback of the low-functioning arm.\n\nLow functioning was defined as pre-treatment upper extremity Fugl-Meyer score of 10-29."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"type":"SECONDARY","title":"Stroke Impact Scale","description":"This test measures the self-reported ability to complete everyday tasks with the arm. Total scores for all items are reported. The scale ranged from 0 to 300, with higher scores indicating higher self-reported ability.","populationDescription":"All participants who started the treatment were included. Data for any participants who failed to complete the treatment were imputed.","reportingStatus":"POSTED","paramType":"MEAN","dispersionType":"Standard Deviation","unitOfMeasure":"score on a scale","timeFrame":"1 month","groups":[{"id":"OG000","title":"Mirror Therapy: High Functioning","description":"4 weeks of home-based mirror therapy. Participants practiced making movements with mirrored visual feedback of the low-functioning arm.\n\nHigh functioning was defined as pre-treatment upper extremity Fugl-Meyer score of 30-50."},{"id":"OG001","title":"Mirror Therapy: Low Functioning","description":"4 weeks of home-based mirror therapy. Participants practiced making movements with mirrored visual feedback of the low-functioning arm.\n\nLow functioning was defined as pre-treatment upper extremity Fugl-Meyer score of 10-29."},{"id":"OG002","title":"Divider Therapy: High Functioning","description":"4 weeks of home-based divider therapy (control therapy to mirror therapy; mirror replaced by a divider). Participants practiced making movements with no visual feedback of the low-functioning arm.\n\nHigh functioning was defined as pre-treatment upper extremity Fugl-Meyer score of 30-50."},{"id":"OG003","title":"Divider Therapy: Low Functioning","description":"4 weeks of home-based divider therapy (control therapy to mirror therapy; mirror replaced by a divider). Participants practiced making movements with no visual feedback of the low-functioning arm.\n\nLow functioning was defined as pre-treatment upper extremity Fugl-Meyer score of 10-29."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"25"},{"groupId":"OG001","value":"23"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"15"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"221.0","spread":"32.5"},{"groupId":"OG001","value":"231.6","spread":"43.7"},{"groupId":"OG002","value":"237.8","spread":"25.7"},{"groupId":"OG003","value":"217.0","spread":"26.7"}]}]}],"analyses":[{"groupIds":["OG000","OG001","OG002","OG003"],"nonInferiorityType":"SUPERIORITY","nonInferiorityComment":"Test for the superiority of Mirror therapy over Divider therapy.","pValue":".28","pValueComment":"ANCOVA analysis with post-treatment score as the dependent variable, therapy type (Mirror therapy or Divider Therapy) as the independent variable, and pre-treatment score as the covariate. P-value reported is for the main effect of therapy type.","statisticalMethod":"ANCOVA","paramType":"Slope","paramValue":"10.7","ciNumSides":"TWO_SIDED"}]},{"type":"SECONDARY","title":"Wolf Motor Function Test","description":"The test measures the ability to completed simulated everyday tasks with the arm. The scale ranged from 0 to 75, with higher scores indicating better performance.","populationDescription":"All participants who started the treatment were included. Data for any participants who failed to complete the treatment were imputed.","reportingStatus":"POSTED","paramType":"MEAN","dispersionType":"Standard Deviation","unitOfMeasure":"score on a scale","timeFrame":"1 months","groups":[{"id":"OG000","title":"Mirror Therapy: High Functioning","description":"4 weeks of home-based mirror therapy. Participants practiced making movements with mirrored visual feedback of the low-functioning arm.\n\nHigh functioning was defined as pre-treatment upper extremity Fugl-Meyer score of 30-50."},{"id":"OG001","title":"Mirror Therapy: Low Functioning","description":"4 weeks of home-based mirror therapy. Participants practiced making movements with mirrored visual feedback of the low-functioning arm.\n\nLow functioning was defined as pre-treatment upper extremity Fugl-Meyer score of 10-29."},{"id":"OG002","title":"Divider Therapy: High Functioning","description":"4 weeks of home-based divider therapy (control therapy to mirror therapy; mirror replaced by a divider). Participants practiced making movements with no visual feedback of the low-functioning arm.\n\nHigh functioning was defined as pre-treatment upper extremity Fugl-Meyer score of 30-50."},{"id":"OG003","title":"Divider Therapy: Low Functioning","description":"4 weeks of home-based divider therapy (control therapy to mirror therapy; mirror replaced by a divider). Participants practiced making movements with no visual feedback of the low-functioning arm.\n\nLow functioning was defined as pre-treatment upper extremity Fugl-Meyer score of 10-29."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"25"},{"groupId":"OG001","value":"23"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"15"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"50.0","spread":"10.0"},{"groupId":"OG001","value":"22.3","spread":"6.0"},{"groupId":"OG002","value":"50.4","spread":"13.8"},{"groupId":"OG003","value":"24.7","spread":"6.7"}]}]}],"analyses":[{"groupIds":["OG000","OG001","OG002","OG003"],"nonInferiorityType":"SUPERIORITY","nonInferiorityComment":"Test for the superiority of Mirror therapy over Divider therapy.","pValue":".86","pValueComment":"ANCOVA analysis with post-treatment score as the dependent variable, therapy type (Mirror therapy or Divider Therapy) as the independent variable, and pre-treatment score as the covariate. P-value reported is for the main effect of therapy type.","statisticalMethod":"ANCOVA","paramType":"Slope","paramValue":"-.36","ciNumSides":"TWO_SIDED"}]}]},"adverseEventsModule":{"frequencyThreshold":"0","timeFrame":"From Baseline screening until 3-month post-treatment follow-up.","eventGroups":[{"id":"EG000","title":"Mirror Therapy: High Functioning","description":"4 weeks of home-based mirror therapy. Participants practiced making movements with mirrored visual feedback of the low-functioning arm.\n\nHigh functioning was defined as pre-treatment upper extremity Fugl-Meyer score of 30-50.","deathsNumAffected":0,"deathsNumAtRisk":25,"seriousNumAffected":0,"seriousNumAtRisk":25,"otherNumAffected":0,"otherNumAtRisk":25},{"id":"EG001","title":"Mirror Therapy: Low Functioning","description":"4 weeks of home-based mirror therapy. Participants practiced making movements with mirrored visual feedback of the low-functioning arm.\n\nLow functioning was defined as pre-treatment upper extremity Fugl-Meyer score of 10-29.","deathsNumAffected":0,"deathsNumAtRisk":23,"seriousNumAffected":0,"seriousNumAtRisk":23,"otherNumAffected":0,"otherNumAtRisk":23},{"id":"EG002","title":"Divider Therapy: High Functioning","description":"4 weeks of home-based divider therapy (control therapy to mirror therapy; mirror replaced by a divider). Participants practiced making movements with no visual feedback of the low-functioning arm.\n\nHigh functioning was defined as pre-treatment upper extremity Fugl-Meyer score of 30-50.","deathsNumAffected":0,"deathsNumAtRisk":9,"seriousNumAffected":0,"seriousNumAtRisk":9,"otherNumAffected":0,"otherNumAtRisk":9},{"id":"EG003","title":"Divider Therapy: Low Functioning","description":"4 weeks of home-based divider therapy (control therapy to mirror therapy; mirror replaced by a divider). Participants practiced making movements with no visual feedback of the low-functioning arm.\n\nLow functioning was defined as pre-treatment upper extremity Fugl-Meyer score of 10-29.","deathsNumAffected":0,"deathsNumAtRisk":15,"seriousNumAffected":0,"seriousNumAtRisk":15,"otherNumAffected":0,"otherNumAtRisk":15}]},"moreInfoModule":{"certainAgreement":{"piSponsorEmployee":false,"restrictiveAgreement":false},"pointOfContact":{"title":"Dr. Steven Jax","organization":"Albert Einstein Healthcare Network","email":"stevenandrewjax@gmail.com","phone":"215-870-0196"}}},"documentSection":{"largeDocumentModule":{"largeDocs":[{"typeAbbrev":"Prot_SAP","hasProtocol":true,"hasSap":true,"hasIcf":false,"label":"Study Protocol and Statistical Analysis Plan","date":"2016-10-17","uploadDate":"2019-01-18T16:18","filename":"Prot_SAP_000.pdf","size":701142}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000010291","term":"Paresis"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000009461","term":"Neurologic Manifestations"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M20634","name":"Muscle Weakness","relevance":"LOW"},{"id":"M12894","name":"Paresis","asFound":"Hemiparesis","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M12094","name":"Neurologic Manifestations","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC05","name":"Musculoskeletal Diseases"},{"abbrev":"BC23","name":"Symptoms and General Pathology"}]}},"hasResults":true}